The stock of Boston Scientific Corp (NYSE:BSX) last traded at $101.64, up 1.33% from the previous session.
BSX stock price is now 11.10% away from the 50-day moving average and 24.78% away from the 200-day moving average. The market capitalization of the company currently stands at $149.80B.
With the price target maintained at $108, Deutsche Bank recently Upgraded its rating from Hold to Buy for Boston Scientific Corp (NYSE: BSX). , while ‘Goldman’ rates the stock as ‘Buy’
In other news, Sorenson John Bradley, EVP, Global Operations sold 4,119 shares of the company’s stock on Jan 02 ’25. The stock was sold for $370,792 at an average price of $90.02. Upon completion of the transaction, the EVP, Global Operations now directly owns 35,319 shares in the company, valued at $3.59 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 03 ’25, EVP, Global Operations Sorenson John Bradley sold 2,342 shares of the business’s stock. A total of $210,449 was realized by selling the stock at an average price of $89.86. This leaves the insider owning 32,977 shares of the company worth $3.35 million. A total of 0.43% of the company’s stock is owned by insiders.
During the past 12 months, Boston Scientific Corp has had a low of $59.85 and a high of $101.65. As of last week, the company has a debt-to-equity ratio of 0.54, a current ratio of 1.48, and a quick ratio of 1.02. According to the stock market information, the enterprise value for the company is $158803820544, which is based on a 84.07 price-to-earnings ratio, a 5.92 price-to-earnings-growth ratio, and a beta of 0.81. The fifty day moving average price for BSX is $91.186 and a two-hundred day moving average price translates $81.2917 for the stock.
The latest earnings results from Boston Scientific Corp (NYSE: BSX) was released for 2024-09-30. The net profit margin was 11.26% and return on equity was 9.05% for BSX. The company reported revenue of $4.21 billion for the quarter, compared to $3.53 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 19.34 percent. For the current quarter, analysts expect BSX to generate $4.42B in revenue.
